Aclarubicin

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

L01DB04

CAS registry number (Chemical Abstracts Service)

0057576-44-0

Chemical Formula

C42-H53-N-O15

Molecular Weight

811

Therapeutic Category

Antineoplastic antibacterial

Chemical Name

Methyl (1R,2R,4S)-2-ethyl-1,2,3,4,6,11-hexahydro-2,5,7-trihydroxy-6,11-dioxo-4-[[2,3,6-trideoxy-4-O-[2,6-dideoxy-4-O-[(2R,6$IS)-tetrahydro-6-methyl-5-oxo-2H-pyran-2-yl]-α-L-lyxo-hexopyranosyl]-3-(dimethylamino)-α-L-lyxo-hexopyranosyl]oxy]-1-naphthacenecar (WHO)

Foreign Names

• Aclarubicinum (Latin)
• Aclarubicin (German)
• Aclarubicine (French)
• Aclarubicina (Spanish)

Generic Names

• Aclarubicin (OS: USAN, BAN)
• Aclarubicine (OS: DCF)
• ACLA (IS)
• Aclacinomycine A (IS)
• Aclarubicin Hydrochloride (OS: BANM)
• Aclarubicin Hydrochloride (PH: JP XV)

Brand Name

• Aclacinon
  Mercian Coperation, Japan

International Drug Name Search

Glossary

BAN	British Approved Name
BANM	British Approved Name (Modified)
DCF	Dénomination Commune Française
IS	Inofficial Synonym
OS	Official Synonym
PH	Pharmacopoeia Name
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)
USAN	United States Adopted Name
WHO	World Health Organization

Click for further information on drug naming conventions and International Nonproprietary Names.